Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 16, 2023; 11(23): 5440-5446
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5440
Table 1 Comparison of the time to disappearance of all relevant clinical symptoms after treatment between the study groups (mean ± SD, h)
Grouping
Number of examples
Time for abdominal pain to disappear
Time for fever to disappear
Time for diarrhea to disappear
Time for nausea and vomiting to disappear
Reference group5622.17 ± 1.457.48 ± 0.779.90 ± 0.936.69 ± 1.17
Experimental group5620.04 ± 1.336.82 ± 0.658.11 ± 0.875.55 ± 1.20
t value-8.1014.90110.5185.909
P value-0.0000.0000.0000.000
Table 2 Comparison of the changes in visual pain analog scale scores for severity of abdominal pain before and after treatment between the study groups (mean ± SD, points)
Grouping
Number of examples
Before treatment
After 0.5 h of treatment
1 h after treatment
6 h after treatment
Reference group567.52 ± 1.135.08 ± 1.044.17 ± 0.963.76 ± 0.82
Experimental group567.44 ± 1.254.22 ± 0.803.79 ± 0.622.77 ± 0.69
t value-0.3554.9052.4886.913
P value-0.7230.0000.0140.000
Table 3 Comparison of the differences in efficacy between the study groups after treatment, n (%)
Grouping
Number of examples
Visible effect
Effective
Invalid
Total efficiency
Reference group5629 (51.79)16 (28.57)11 (19.64)45 (80.36)
Experimental group5633 (58.93)20 (35.71)3 (5.36)53 (94.64)
χ2----5.224
P value----0.022
Table 4 Comparison of the differences in the occurrence of adverse reactions after treatment between the study groups, n (%)
Grouping
Number of examples
Blurred vision
Dry mouth
Heart palpitations
Total incidence
Reference group562 (3.57)6 (10.71)4 (7.14)12 (21.43)
Experimental group560 (0.00)3 (5.36)1 (1.79)4 (7.14)
χ2----4.667
P value----0.031